IMPROVED SURVIVAL IN LEFT NON-SMALL-CELL N2 LUNG-CANCER AFTER MORE EXTENSIVE OPERATIVE PROCEDURE

被引:28
|
作者
WATANABE, Y
SHIMIZU, J
ODA, M
HAYASHI, Y
TATSUZAWA, Y
WATANABE, S
YOSHIDA, M
IWA, T
机构
[1] Department of Surgery, Kanazawa University, School of Medicine, Kanazawa 920
来源
THORACIC AND CARDIOVASCULAR SURGEON | 1991年 / 39卷 / 02期
关键词
LEFT LUNG CANCER; N2; DISEASE; EXTENSIVE LYMPH NODE DISSECTION; MEDIAN STERNOTOMY; SUBCARINAL NODE;
D O I
10.1055/s-2007-1013939
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The five-year survival rate of lung-cancer patients with left-sided N2 non-small-cell disease is worse than that for those with right-sided lesions and this is partly caused by inadequate nodal dissection due to anatomical limitations. To overcome the problem of performing nodal dissection in the left mediastinum, several modifications of the operative technique have been tried in the past 18 years. The survival rates of the patients treated by each procedure were retrospectively compared in this study. The dissection method for mediastinal nodes was modified at three periods (1973-1980, 1981-1985, and 1986-1990). The first period involved less extensive node dissection, in the second period more extensive dissection was enabled by mobilization of the aortic arch, and in the most recent systematic and extensive dissection was made possible by the use of a median sternotomy. The five-year survival rates of the left-sided N2 patients undergoing complete resection in the first and second period were 8.3%, and 15.4%, respectively. The three-year survival rate in the most recent period has risen to 30.8%. Complete and extensive dissection of the mediastinal nodes after performing a median sternotomy is the procedure of choice for lung-cancer patients with left-sided N2 disease.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 50 条
  • [1] SURVIVAL FOLLOWING RESECTION OF CLINICALLY OCCULT N2 NON-SMALL-CELL LUNG-CANCER
    DALTON, R
    KELLER, S
    [J]. JOURNAL OF CARDIOVASCULAR SURGERY, 1994, 35 (06): : 13 - 17
  • [2] Subclassification of N2 non-small-cell lung cancer
    Grannis, FW
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1228 - 1228
  • [3] SURVIVAL AFTER RESECTION OF STAGE-II NON-SMALL-CELL LUNG-CANCER
    MARTINI, N
    BURT, ME
    BAINS, MS
    TODD, TRJ
    MCCORMACK, PM
    RUSCH, VW
    GINSBERG, RJ
    CHAMBERS, JS
    [J]. ANNALS OF THORACIC SURGERY, 1992, 54 (03): : 460 - 466
  • [4] Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer
    Higgins, Kristin A.
    Chino, Junzo P.
    Ready, Neal
    Onaitis, Mark W.
    Berry, Mark F.
    D'Amico, Thomas A.
    Kelsey, Chris R.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 142 (05): : 1175 - 1179
  • [5] Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA(N2) Non-Small-Cell Lung Cancer
    Koshy, Matthew
    Fedewa, Stacey A.
    Malik, Renu
    Ferguson, Mark K.
    Vigneswaran, Wickii T.
    Feldman, Lawrence
    Howard, Andrew
    Abdelhady, Khaled
    Weichselbaum, Ralph R.
    Virgo, Katherine S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : 915 - 922
  • [6] Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA (N2) Non-Small-Cell Lung Cancer
    Poullis, Michael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (11) : E100 - E100
  • [7] Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications
    Andre, F
    Grunenwald, D
    Pignon, JP
    Dujon, A
    Pujol, JL
    Brichon, PY
    Brouchet, L
    Quoix, E
    Westeel, V
    Le Chevalier, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2981 - 2989
  • [8] TREATMENT OF N2 NON-SMALL CELL LUNG-CANCER (NSCLC)
    KLASTERSKY, J
    FELD, R
    KLEISBAUER, JP
    ROCMANS, P
    [J]. CHEST, 1989, 96 (01) : S83 - S85
  • [9] SURVIVAL ANALYSIS OF UNTREATED PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    VRDOLJAK, E
    MISE, K
    SAPUNAR, D
    ROZGA, A
    MARUSIC, M
    [J]. CHEST, 1994, 106 (06) : 1797 - 1800
  • [10] SURVIVAL IN EARLY-STAGE NON-SMALL-CELL LUNG-CANCER
    NESBITT, JC
    PUTNAM, JB
    WALSH, GL
    ROTH, JA
    MOUNTAIN, CF
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (02): : 466 - 472